Authors: Walter, H Schmidt, B Rascu, A Helm, M Moschik, B Paatz, C Kurowski, M Korn, K Uberla, K Harrer, T

Citation: H. Walter et al., Phenotypic HIV-1 resistance correlates with treatment outcome of nelfinavir salvage therapy, ANTIVIR TH, 5(4), 2000, pp. 249-256

Authors: Wintergerst, U Engelhorn, C Kurowski, M Hoffmann, F Notheis, G Belohradsky, BH

Citation: U. Wintergerst et al., Pharmacokinetic interaction of amprenavir in combination with efavirenz ordelavirdine in HIV-infected children, AIDS, 14(12), 2000, pp. 1866-1868

Authors: Schuster, T Linde, R Wintergerst, U Funk, MB Kurowski, M Kreuz, W Hofmann, D

Citation: T. Schuster et al., Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing, AIDS, 14(10), 2000, pp. 1466-1468

Authors: Wintergerst, U Kurowski, M Rolinski, B Muller, M Wolf, E Jaeger, H Belohradsky, BH

Citation: U. Wintergerst et al., Use of saliva specimens for monitoring indinavir therapy in human immunodeficiency virus-infected patients, ANTIM AG CH, 44(9), 2000, pp. 2572-2574

Authors: Guerrero, RAA Amuchastegui, M Badaracco, J Elizari, M Martellotto, R De la Hoz, RP Ramos, JL Salvati, AM Sinisi, A Torre, H Aroney, G Campbell, T Garrahy, P",Lalman,"Liebens, I Renard, M Bastecky, J Bocek, P Cepelak, V Dvorak, K Gregor, J Janousek, S Jansky, P Jirmar, R Kamenik, L Rybka, J Spacek, R Spinar, J Svitil, P Zeman, K Alagha, Z Allam, S Barnay, C Baudouy, M Beltran, J Berland, J Berthou, JD Bery, E Bessede, G Beygui, F Bickert, P Boshat, J Boulenc, JM Bourlard, P Bouthillier, D Brandt, C Cattan, S Charbonnier, B Citron, B Coisne, D Coupillaud, J Da Costa, A Dambrine, P Danchin, N Delarche, N Dequeker, JL Desjouaux, E Dievart, F Dujardin, JJ Durand, P Fadel, N Fichter, P Galinier, M Gryman, R Gauthier, J Geslin, P Godard, S Grollier, G Guerot, C Gully, C Janin-Manificat, L Joly, P Joseph, T Juillard, A Ketelers, JY Lagorce, P Laine, E Lang, M Lanney-Courten, JE Le Helloco, A Ledru, F Levy, S Litvine-Itaya, L Lopez, M Mansour, M Mathurin, C Meyer, G Mossaz, R Nedelec, G Ollitrault, J Pacouret, G Perchet, H Poitrineau, O Richard, M Rocher, R Rougier, L Sagnol, P Tardieu, A Thery, C Thieuleux, F Touboul, P Tran-Tanh, X Veyrat, A Villarem, D Werquin, S Skoufas, P Fotiadis, I Xenodochidis, C Karidis, K Limberi, S Papasteriadis, E Giokas, K Kremastinos, D Polichronaki, E Moshos, N Daskalakis, I Janecsko, M Janosi, A Kalo, E Karpati, P Mezofi, M Nyaradi, A Ofner, P Oze, B Poor, F Preda, I Ronaszeki, A Valyi, P Zamolyi, K Davini, P Martines, C Melandri, F Pasotti, C Pettinati, G Veze, I Kochkarev, F Erpelding, J Halaczkiewicz, H Ilmuzynska, K Kurowski, M Lasota-Czopnik, A Markiewicz, M Musial, W Nartowicz, E Pasyk, S Prastowski, W Ruszkowski, J Sadowski, Z Sas, M Stopinski, M Ujda, M Wojciechowski, D Diniz, M Drumond, A Rodrigues, P Pereira, MA Correia, A Scherbak, A Irklienko, K Dudko, L Goloschekin, B Maximova, G Sorokin, L Inyushin, A Bzhelianskaia, V Kostenko, V Stefanenko, M Bilich, A Froufe, G Masip, J Pajaron, A Roura, J Sanz, G Valle, V Caduff, B Moccetti, T Noseda, G Simonin, C Baars, HF Bernink, PJLM Daniels, MCG Gobel, E Nagelsmit, MJ Ramdat, AR Senden, PJ van Rossum, P van Wijk, LM Withagen, AJAM Crowe, PF Davidson, C Handler, CE",McNeil,"Molajo, AO

Citation: Raa. Guerrero et al., Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAXIS (FRAxiparine in Ischaemic Syndrome), EUR HEART J, 20(21), 1999, pp. 1553-1562